Boceprevir Impurity 15 CAS CATO-C4X-252515
| CAS No. | CATO-C4X-252515 |
| Molecular Formula | C13H14F3N5O3 |
| Molecular Weight | 345.28 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
CATO supplies Boceprevir Impurity 15 (CAS CATO-C4X-252515), a pharmacopoeial impurity reference standard (molecular formula C13H14F3N5O3, MW 345.28 g/mol) used for the identification and quantification of trace impurities in APIs.
The molecular framework of Boceprevir Impurity 15 (C13H14F3N5O3) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, fluorine substitution. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C13H14F3N5O3 |
| Molecular Weight | 345.28 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 8.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | F-containing |
| Nitrogen Atoms | 5 |
Related Boceprevir Standards
- Boceprevir impurity 23 (CAS 2755812-45-2)
- Boceprevir Metabolite M4 (CAS 816444-90-3)
- Boceprevir Impurity 20 (CAS 328086-57-3)
- Boceprevir Metabolite M4-d (CAS 1158083-48-7)
- Boceprevir Impurity 10 (CAS CATO-C4X-252510)
- Boceprevir Impurity 12 (CAS CATO-C4X-252512)
- Boceprevir Impurity 11 (CAS CATO-C4X-252511)
- Boceprevir Impurity 21 (CAS 1568066-82-9)
Recommended Standards
- Brexpiprazole Impurity 138 (CAS CATO-C4X-1131138)
- Methyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoate (CAS 1195768-19-4)
- Aristolochic Acid A-13C,d3 (CAS CATO-C3D-5883)
- 2-Nitro-1-tosyl-4-(trifluoromethyl)benzene (CAS 127291-63-8)
- Torasemide Impurity 8 (CAS 69300-04-5)
- Sarpogrelate Impurity 18 (CAS 1659311-47-3(free base))
- Irinotecan Impurity 29 (CAS CATO-C4X-166729)
- 4-Methylfuran-2-carbonyl Chloride (CAS 39272-49-6)
- 4,4'-((tert-Butoxycarbonyl)azanediyl)dibutyric acid (CAS 1204700-92-4)
- 5-Bromo-N-(4-methoxyphenyl)pyrimidin-2-amine (CAS 76226-01-2)
- 1-(3-Chlorophenyl)-3-(furan-2-ylmethyl)urea (CAS 541530-15-8)
- 5-Phenylpicolinic acid (CAS 75754-04-0)
- 5-(Cyclopropylamino)-1,3,4-thiadiazole-2-thiol (CAS 852400-37-4)
- Hepcidin/LEAP-1 (Human); Liver-Expressed Antimicrobial Peptide (CAS 342790-21-0)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com